| Roxana Gabriella Bantle, MD | |
|
13700 St Francis Blvd, Ste 501, Midlothian, VA 23114-3222 | |
| (804) 378-4420 | |
| (804) 378-4440 |
| Full Name | Roxana Gabriella Bantle |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 13700 St Francis Blvd, Midlothian, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417906801 | NPI | - | NPPES |
| 010294568 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101240121 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Roxana Gabriella Bantle, MD 10519 Brightstone Dr, Midlothian, VA 23112-1570 Ph: (804) 378-4420 | Roxana Gabriella Bantle, MD 13700 St Francis Blvd, Ste 501, Midlothian, VA 23114-3222 Ph: (804) 378-4420 |
News Archive
As interest in concussion rates and prevention strategies at all levels continues to grow, one population that appears to have increasing head injury rates is collegiate football players.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.
Many experts now consider colon cancer a largely preventable disease, but a new study finds that primary care doctors might not always inform patients about one important step they can take to reduce their risk: becoming more physically active.
A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (cancer that has not spread beyond the ovary). But it remains unclear which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail.
The U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.
› Verified 9 days ago
Dr. Joel C Everett, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13821 Village Mill Dr, Midlothian, VA 23114 Phone: 804-794-2821 Fax: 804-794-4072 | |
Arpita Gupta Depalma, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11601 Robious Rd, Suite 100, Midlothian, VA 23113 Phone: 804-379-9494 | |
Dr. Linda A Burk, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 16213 Saville Chase Ln, Midlothian, VA 23112 Phone: 804-432-8817 | |
Dr. Gordon Neil Kellett Ii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13821 Village Mill Dr, Midlothian, VA 23114 Phone: 804-794-2821 Fax: 804-794-4072 | |
Dr. Mark A Flanzenbaum, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5021 Craig Rath Blvd Bldg 4, Midlothian, VA 23112 Phone: 804-592-5437 Fax: 804-474-9071 | |
Dr. Elizabeth Marie Cullen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1407 Huguenot Rd, Midlothian, VA 23113 Phone: 804-794-2299 Fax: 804-794-5774 | |
Isca Rochelle Wilms, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13700 St Francis Blvd, Suite 501, Midlothian, VA 23114 Phone: 804-378-4420 Fax: 804-378-4440 |